Kinase modulators
US-11858907-B2 · Jan 2, 2024 · US
This page is not indexed by search engines while we improve data quality.
Rhizen Pharmaceuticals Ag patents
Rhizen Pharmaceuticals Ag holds 4 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 4 |
| Recent patents | 1 |
| First publication | Jun 7, 2022 |
| Latest publication | Jan 2, 2024 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Process for preparation of optically pure and optionally substituted 2-(1-hydroxy-alkyl)-chromen-4-one derivatives and their use in preparing pharmaceuticals
US-11478481-B2 · Oct 25, 2022 · US
Dual selective PI3 delta and gamma kinase inhibitors
US-11466006-B2 · Oct 11, 2022 · US
PI3K protein kinase inhibitors
US-11352359-B2 · Jun 7, 2022 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Kinase modulators
US-11858907-B2 · Jan 2, 2024 · US
Process for preparation of optically pure and optionally substituted 2-(1-hydroxy-alkyl)-chromen-4-one derivatives and their use in preparing pharmaceuticals
US-11478481-B2 · Oct 25, 2022 · US
Dual selective PI3 delta and gamma kinase inhibitors
US-11466006-B2 · Oct 11, 2022 · US
PI3K protein kinase inhibitors
US-11352359-B2 · Jun 7, 2022 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 4 |
| Chemistry & Metallurgy | 4 |
| Cross-Sectional Technologies | 1 |